Feasibility and Efficacy of Virtual Reality Interventions to Improve Psychosocial Functioning in Psychosis: Systematic Review

Alexandra H Schroeder, Bryce J M Bogie, Tabassum T Rahman, Alexandra Thérond, Hannah Matheson, Synthia Guimond, Alexandra H Schroeder, Bryce J M Bogie, Tabassum T Rahman, Alexandra Thérond, Hannah Matheson, Synthia Guimond

Abstract

Background: Functional recovery in psychosis remains a challenge despite current evidence-based treatment approaches. To address this problem, innovative interventions using virtual reality (VR) have recently been developed. VR technologies have enabled the development of realistic environments in which individuals with psychosis can receive psychosocial treatment interventions in more ecological settings than traditional clinics. These interventions may therefore increase the transfer of learned psychosocial skills to real-world environments, thereby promoting long-term functional recovery. However, the overall feasibility and efficacy of such interventions within the psychosis population remain unclear.

Objective: This systematic review aims to investigate whether VR-based psychosocial interventions are feasible and enjoyable for individuals with psychosis, synthesize current evidence on the efficacy of VR-based psychosocial interventions for psychosis, and identify the limitations in the current literature to guide future research.

Methods: This research followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Literature searches were conducted in PubMed and PsycINFO in May 2021. We searched for peer-reviewed English articles that used a psychosocial intervention with a VR component. Participants in the included studies were diagnosed with schizophrenia, schizoaffective disorder, or another psychotic disorder. The included studies were divided into four categories as follows: cognitive remediation interventions, social skills interventions, vocational skills interventions, and auditory verbal hallucinations and paranoia interventions. The risk of bias assessment was performed for each study.

Results: A total of 18 studies were included in this systematic review. Of these 18 studies, 4 (22%) studies used a cognitive remediation intervention, 4 (22%) studies used a social skills intervention, 3 (17%) studies used a vocational skills intervention, and 7 (39%) studies implemented an intervention aimed at improving auditory verbal hallucinations or paranoia. A total of 745 individuals with psychosis were included in the study. All the studies that evaluated feasibility showed that VR-based psychosocial interventions were feasible and enjoyable for individuals with psychosis. The preliminary evidence on efficacy included in this review suggests that VR-based psychosocial interventions can improve cognitive, social, and vocational skills in individuals with psychosis. VR-based interventions may also improve the symptoms of auditory verbal hallucinations and paranoia. The skills that participants learned through these interventions were durable, transferred into real-world environments, and led to improved functional outcomes, such as autonomy, managing housework, and work performance.

Conclusions: VR-based interventions may represent a novel and efficacious approach for improving psychosocial functioning in psychosis. Therefore, VR-based psychosocial interventions represent a promising adjunctive therapy for the treatment of psychosis, which may be used to improve psychosocial skills, community functioning, and quality of life.

Keywords: auditory verbal hallucinations; cognitive remediation; functional outcomes; neurocognition; paranoia; psychosis; schizophrenia; social skills; virtual reality (VR); vocational skills.

Conflict of interest statement

Conflicts of Interest: None declared.

©Alexandra H Schroeder, Bryce J M Bogie, Tabassum T Rahman, Alexandra Thérond, Hannah Matheson, Synthia Guimond. Originally published in JMIR Mental Health (https://mental.jmir.org), 18.02.2022.

Figures

Figure 1
Figure 1
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram. VR: virtual reality.
Figure 2
Figure 2
Virtual reality environments developed via the NeuroVr 2.0 software for a cognitive remediation intervention in schizophrenia. The environments include a park (A), valley (B), beach (C), and supermarket (D). Images reproduced with author permission from La Paglia [46].
Figure 3
Figure 3
Virtual reality environment used in the Multimodal Adaptive Social Intervention in virtual reality. (A) The cafeteria environment and (B) the bus stop environment where participants can practice "small talk" and interact with the avatars. (C) The participant chooses what to say to the avatar from a multiple-choice menu. (D) The avatar provides feedback after the exchange with the participant. Reprinted from Psychiatry Research, Adery et al [48], Copyright 2018, with permission from Elsevier.
Figure 4
Figure 4
Virtual reality environment used in the Soskitrain virtual reality integrated program for improving social skills in patients with schizophrenia. Participants can practice social interactions with avatars, such as (A) a bartender and (B) a security guard in a museum. Unpublished images reproduced from the Soskitrain program with author permission from Rus-Calafell [50].

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (DSM-5®) Arlington, VA: American Psychiatric Publishing; 2013.
    1. Kelly S, Guimond S, Lyall A, Stone WS, Shenton ME, Keshavan M, Seidman LJ. Neural correlates of cognitive deficits across developmental phases of schizophrenia. Neurobiol Dis. 2019 Nov;131:104353. doi: 10.1016/j.nbd.2018.12.013.S0969-9961(18)30769-1
    1. Fett AJ, Viechtbauer W, Dominguez M, Penn DL, van Os J, Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev. 2011 Jan;35(3):573–88. doi: 10.1016/j.neubiorev.2010.07.001.S0149-7634(10)00114-4
    1. Silva MA, Restrepo D. Functional recovery in schizophrenia. Rev Colomb Psiquiatr (Engl Ed) 2019;48(4):252–60. doi: 10.1016/j.rcp.2017.08.004.S0034-7450(17)30114-2
    1. Arciniegas DB. Psychosis. CONTINUUM Lifelong Learn Neurol. 2015;21:715–36. doi: 10.1212/01.con.0000466662.89908.e7.
    1. Rabinowitz J, Berardo CG, Bugarski-Kirola D, Marder S. Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: a CATIE analysis. Schizophr Res. 2013 Nov;150(2-3):339–42. doi: 10.1016/j.schres.2013.07.014. S0920-9964(13)00358-7
    1. Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, Castle DJ, Citrome L, Daskalakis ZJ, Davidson M, Drake RJ, Dursun S, Ebdrup BH, Elkis H, Falkai P, Fleischacker WW, Gadelha A, Gaughran F, Glenthøj BY, Graff-Guerrero A, Hallak JE, Honer WG, Kennedy J, Kinon BJ, Lawrie SM, Lee J, Leweke FM, MacCabe JH, McNabb CB, Meltzer H, Möller H-J, Nakajima S, Pantelis C, Reis Marques T, Remington G, Rossell SL, Russell BR, Siu CO, Suzuki T, Sommer IE, Taylor D, Thomas N, Üçok A, Umbricht D, Walters JT, Kane J, Correll CU. Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 2017 Mar 01;174(3):216–29. doi: 10.1176/appi.ajp.2016.16050503.
    1. Lally J, Ajnakina O, Stubbs B, Cullinane M, Murphy KC, Gaughran F, Murray RM. Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies. Br J Psychiatry. 2017 Dec;211(6):350–8. doi: 10.1192/bjp.bp.117.201475.S0007125000285632
    1. Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA, CATIE Investigators. Neurocognitive Working Group Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry. 2007 Jun;64(6):633–47. doi: 10.1001/archpsyc.64.6.633.64/6/633
    1. Stępnicki P, Kondej M, Kaczor AA. Current concepts and treatments of schizophrenia. Molecules. 2018 Aug 20;23(8):2087. doi: 10.3390/molecules23082087. molecules23082087
    1. Kucharska-Pietura K, Mortimer A. Can antipsychotics improve social cognition in patients with schizophrenia? CNS Drugs. 2013 May;27(5):335–43. doi: 10.1007/s40263-013-0047-0.
    1. Percudani M, Barbui C, Tansella M. Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective. Pharmacoeconomics. 2004;22(11):701–18. doi: 10.2165/00019053-200422110-00002.22112
    1. Norman R, Lecomte T, Addington D, Anderson E. Canadian treatment guidelines on psychosocial treatment of schizophrenia in adults. Can J Psychiatry. 2017 Sep;62(9):617–23. doi: 10.1177/0706743717719894.
    1. Psychosis and Schizophrenia in Adults: the NICE Guideline on the Treatment and Management of Psychosis and Schizophrenia in Adults. London, England: Royal College of Psychiatrists; 2014.
    1. Turner DT, McGlanaghy E, Cuijpers P, van der Gaag M, Karyotaki E, MacBeth A. A meta-analysis of social skills training and related interventions for psychosis. Schizophr Bull. 2018 Apr 06;44(3):475–91. doi: 10.1093/schbul/sbx146. 4618008
    1. Kurzban S, Davis L, Brekke JS. Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends. Curr Psychiatry Rep. 2010 Aug;12(4):345–55. doi: 10.1007/s11920-010-0129-3.
    1. Matsuda Y, Makinodan M, Morimoto T, Kishimoto T. Neural changes following cognitive remediation therapy for schizophrenia. Psychiatry Clin Neurosci. 2019 Nov;73(11):676–84. doi: 10.1111/pcn.12912. doi: 10.1111/pcn.12912.
    1. Rodríguez-Blanco L, Lubrini G, Vidal-Mariño C, Ríos-Lago M. Efficacy of cognitive rehabilitation of attention, executive functions, and working memory in psychotic disorders: a systematic review. Actas Esp Psiquiatr. 2017 Jul;45(4):167–78.
    1. Suijkerbuijk Y, Schaafsma F, van Mechelen JC, Ojajärvi A, Corbière M, Anema J. Interventions for obtaining and maintaining employment in adults with severe mental illness, a network meta-analysis. Cochrane Database Syst Rev. 2017 Sep 12;9:CD011867. doi: 10.1002/14651858.CD011867.pub2.
    1. McCleery A, Nuechterlein KH. Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations. Dialogues Clin Neurosci. 2019 Sep;21(3):239–48. doi: 10.31887/DCNS.2019.21.3/amccleery.
    1. Bechi M, Bosia M, Spangaro M, Buonocore M, Cavedoni S, Agostoni G, Bianchi L, Cocchi F, Guglielmino C, Smeraldi E, Cavallaro R. Exploring functioning in schizophrenia: predictors of functional capacity and real-world behaviour. Psychiatry Res. 2017 May;251:118–24. doi: 10.1016/j.psychres.2017.02.019.S0165-1781(16)31787-5
    1. Galderisi S, Rucci P, Kirkpatrick B, Mucci A, Gibertoni D, Rocca P, Rossi A, Bertolino A, Strauss GP, Aguglia E, Bellomo A, Murri MB, Bucci P, Carpiniello B, Comparelli A, Cuomo A, De Berardis D, Dell'Osso L, Di Fabio F, Gelao B, Marchesi C, Monteleone P, Montemagni C, Orsenigo G, Pacitti F, Roncone R, Santonastaso P, Siracusano A, Vignapiano A, Vita A, Zeppegno P, Maj M, Italian Network for Research on Psychoses Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis. JAMA Psychiatry. 2018 Apr 01;75(4):396–404. doi: 10.1001/jamapsychiatry.2017.4607. 2671414
    1. Veling W, Moritz S, van der Gaag M. Brave new worlds--review and update on virtual reality assessment and treatment in psychosis. Schizophr Bull. 2014 Nov;40(6):1194–7. doi: 10.1093/schbul/sbu125. sbu125
    1. Park MJ, Kim DJ, Lee U, Na EJ, Jeon HJ. A literature overview of virtual reality (VR) in treatment of psychiatric disorders: recent advances and limitations. Front Psychiatry. 2019 Jul 19;10:505. doi: 10.3389/fpsyt.2019.00505. doi: 10.3389/fpsyt.2019.00505.
    1. Rus-Calafell M, Garety P, Sason E, Craig TJ, Valmaggia LR. Virtual reality in the assessment and treatment of psychosis: a systematic review of its utility, acceptability and effectiveness. Psychol Med. 2018 Feb;48(3):362–91. doi: 10.1017/S0033291717001945.S0033291717001945
    1. Sanchez-Vives MV, Slater M. From presence to consciousness through virtual reality. Nat Rev Neurosci. 2005 Apr;6(4):332–9. doi: 10.1038/nrn1651.nrn1651
    1. Cieślik B, Mazurek J, Rutkowski S, Kiper P, Turolla A, Szczepańska-Gieracha J. Virtual reality in psychiatric disorders: a systematic review of reviews. Complement Ther Med. 2020 Aug;52:102480. doi: 10.1016/j.ctim.2020.102480. S0965-2299(20)30627-0
    1. Maples-Keller JL, Bunnell BE, Kim S, Rothbaum BO. The use of virtual reality technology in the treatment of anxiety and other psychiatric disorders. Harv Rev Psychiatry. 2017;25(3):103–13. doi: 10.1097/hrp.0000000000000138.
    1. Oing T, Prescott J. Implementations of virtual reality for anxiety-related disorders: systematic review. JMIR Serious Games. 2018 Nov 07;6(4):e10965. doi: 10.2196/10965. v6i4e10965
    1. Aida J, Chau B, Dunn J. Immersive virtual reality in traumatic brain injury rehabilitation: a literature review. NeuroRehabilitation. 2018;42(4):441–8. doi: 10.3233/NRE-172361.NRE172361
    1. Maggio MG, Russo M, Cuzzola MF, Destro M, La Rosa G, Molonia F, Bramanti P, Lombardo G, De Luca R, Calabrò RS. Virtual reality in multiple sclerosis rehabilitation: a review on cognitive and motor outcomes. J Clin Neurosci. 2019 Jul;65:106–11. doi: 10.1016/j.jocn.2019.03.017.S0967-5868(19)30185-7
    1. Aramaki AL, Sampaio RF, Reis AC, Cavalcanti A, Dutra FC. Virtual reality in the rehabilitation of patients with stroke: an integrative review. Arq Neuropsiquiatr. 2019 May 13;77(4):268–78. doi: 10.1590/0004-282X20190025. S0004-282X2019000400268
    1. Polese D, Fornaro M, Palermo M, De Luca V, de Bartolomeis A. Treatment-resistant to antipsychotics: a resistance to everything? Psychotherapy in treatment-resistant schizophrenia and nonaffective psychosis: a 25-year systematic review and exploratory meta-analysis. Front Psychiatry. 2019 Apr 17;10:210. doi: 10.3389/fpsyt.2019.00210. doi: 10.3389/fpsyt.2019.00210.
    1. Ali SA, Mathur N, Malhotra AK, Braga RJ. Electroconvulsive therapy and schizophrenia: a systematic review. Mol Neuropsychiatry. 2019 Apr;5(2):75–83. doi: 10.1159/000497376. mnp-0005-0075
    1. Coyle H, Traynor V, Solowij N. Computerized and virtual reality cognitive training for individuals at high risk of cognitive decline: systematic review of the literature. Am J Geriatr Psychiatry. 2015 Apr;23(4):335–59. doi: 10.1016/j.jagp.2014.04.009.S1064-7481(14)00139-0
    1. Keshner EA, Weiss PT, Geifman D, Raban D. Tracking the evolution of virtual reality applications to rehabilitation as a field of study. J Neuroeng Rehabil. 2019 Jun 21;16(1):76. doi: 10.1186/s12984-019-0552-6. 10.1186/s12984-019-0552-6
    1. Freeman D, Reeve S, Robinson A, Ehlers A, Clark D, Spanlang B, Slater M. Virtual reality in the assessment, understanding, and treatment of mental health disorders. Psychol Med. 2017 Oct;47(14):2393–400. doi: 10.1017/S003329171700040X. S003329171700040X
    1. Valmaggia LR, Day F, Rus-Calafell M. Using virtual reality to investigate psychological processes and mechanisms associated with the onset and maintenance of psychosis: a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2016 Jul;51(7):921–36. doi: 10.1007/s00127-016-1245-0.10.1007/s00127-016-1245-0
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.
    1. Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JP. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
    1. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ. In: Cochrane Handbook for Systematic Reviews of Interventions. Welch VA, editor. Hoboken, New Jersey: Wiley; 2021. .
    1. Balk EM, Raman G, Adam GP, Halladay CW, Langberg VN, Azodo IA, Trikalinos TA. Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review. Rockville, MD: Agency for Healthcare Research and Quality; 2016.
    1. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwel P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute. .
    1. Amado I, Brénugat-Herné L, Orriols E, Desombre C, Dos Santos M, Prost Z, Krebs M, Piolino P. A serious game to improve cognitive functions in schizophrenia: a pilot study. Front Psychiatry. 2016 Apr 20;7:64. doi: 10.3389/fpsyt.2016.00064. doi: 10.3389/fpsyt.2016.00064.
    1. Chan CL, Ngai EK, Leung PK, Wong S. Effect of the adapted Virtual Reality cognitive training program among Chinese older adults with chronic schizophrenia: a pilot study. Int J Geriatr Psychiatry. 2010 Jun;25(6):643–9. doi: 10.1002/gps.2403.
    1. La Paglia F, La Cascia C, Rizzo R, Sideli L, Francomano A, La Barbera D. Cognitive rehabilitation of schizophrenia through NeuroVr training. Stud Health Technol Inform. 2013;191:158–62.
    1. La Paglia F, La Cascia C, Rizzo R, Sanna M, Cangialosi F, Sideli L, Francomano A, Riva G, La Barbera D. Virtual reality environments to rehabilitation attention deficits in schizophrenic patients. Annual Rev Cyber Ther Telemed. 2016;14:143–8.
    1. Adery LH, Ichinose M, Torregrossa LJ, Wade J, Nichols H, Bekele E, Bian D, Gizdic A, Granholm E, Sarkar N, Park S. The acceptability and feasibility of a novel virtual reality based social skills training game for schizophrenia: preliminary findings. Psychiatry Res. 2018 Dec;270:496–502. doi: 10.1016/j.psychres.2018.10.014. S0165-1781(18)30383-4
    1. Park K, Ku J, Choi S, Jang H, Park J, Kim SI, Kim J. A virtual reality application in role-plays of social skills training for schizophrenia: a randomized, controlled trial. Psychiatry Res. 2011 Sep 30;189(2):166–72. doi: 10.1016/j.psychres.2011.04.003.S0165-1781(11)00284-8
    1. Rus-Calafell M, Gutiérrez-Maldonado J, Ribas-Sabaté J. A virtual reality-integrated program for improving social skills in patients with schizophrenia: a pilot study. J Behav Ther Exp Psychiatry. 2014 Mar;45(1):81–9. doi: 10.1016/j.jbtep.2013.09.002.S0005-7916(13)00065-7
    1. Vass E, Simon V, Fekete Z, Lencse L, Ecseri M, Kis B, Simon L. A novel virtual reality-based theory of mind intervention for outpatients with schizophrenia: a proof-of-concept pilot study. Clin Psychol Psychother. 2021 May;28(3):727–38. doi: 10.1002/cpp.2519.
    1. Smith MJ, Fleming MF, Wright MA, Roberts AG, Humm LB, Olsen D, Bell MD. Virtual reality job interview training and 6-month employment outcomes for individuals with schizophrenia seeking employment. Schizophr Res. 2015 Aug;166(1-3):86–91. doi: 10.1016/j.schres.2015.05.022. S0920-9964(15)00279-0
    1. Sohn BK, Hwang JY, Park SM, Choi J, Lee J, Lee JY, Jung H. Developing a virtual reality-based vocational rehabilitation training program for patients with schizophrenia. Cyberpsychol Behav Soc Netw. 2016 Nov;19(11):686–91. doi: 10.1089/cyber.2016.0215.
    1. Tsang MM, Man DW. A virtual reality-based vocational training system (VRVTS) for people with schizophrenia in vocational rehabilitation. Schizophr Res. 2013 Mar;144(1-3):51–62. doi: 10.1016/j.schres.2012.12.024.S0920-9964(13)00011-X
    1. Dellazizzo L, Potvin S, Phraxayavong K, Dumais A. Exploring the benefits of virtual reality-assisted therapy following cognitive-behavioral therapy for auditory hallucinations in patients with treatment-resistant schizophrenia: a proof of concept. J Clin Med. 2020 Sep 30;9(10):3169. doi: 10.3390/jcm9103169. jcm9103169
    1. Dellazizzo L, Potvin S, Phraxayavong K, Dumais A. One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia. NPJ Schizophr. 2021 Mar 12;7(1):9. doi: 10.1038/s41537-021-00139-2. doi: 10.1038/s41537-021-00139-2.10.1038/s41537-021-00139-2
    1. du Sert OP, Potvin S, Lipp O, Dellazizzo L, Laurelli M, Breton R, Lalonde P, Phraxayavong K, O'Connor K, Pelletier J, Boukhalfi T, Renaud P, Dumais A. Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: a pilot clinical trial. Schizophr Res. 2018 Jul;197:176–81. doi: 10.1016/j.schres.2018.02.031.S0920-9964(18)30108-7
    1. Geraets CN, Snippe E, van Beilen M, Pot-Kolder RM, Wichers M, van der Gaag M, Veling W. Virtual reality based cognitive behavioral therapy for paranoia: effects on mental states and the dynamics among them. Schizophr Res. 2020 Aug;222:227–34. doi: 10.1016/j.schres.2020.05.047. S0920-9964(20)30301-7
    1. Moritz S, Voigt M, Köther U, Leighton L, Kjahili B, Babur Z, Jungclaussen D, Veckenstedt R, Grzella K. Can virtual reality reduce reality distortion? Impact of performance feedback on symptom change in schizophrenia patients. J Behav Ther Exp Psychiatry. 2014 Jun;45(2):267–71. doi: 10.1016/j.jbtep.2013.11.005.S0005-7916(13)00102-X
    1. Pot-Kolder RM, Geraets CN, Veling W, van Beilen M, Staring AB, Gijsman HJ, Delespaul PA, van der Gaag M. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial. Lancet Psychiatry. 2018 Mar;5(3):217–26. doi: 10.1016/S2215-0366(18)30053-1.S2215-0366(18)30053-1
    1. Pot-Kolder R, Veling W, Geraets C, Lokkerbol J, Smit F, Jongeneel A, Ising H, van der Gaag M. Cost-effectiveness of virtual reality cognitive behavioral therapy for psychosis: health-economic evaluation within a randomized controlled trial. J Med Internet Res. 2020 May 05;22(5):e17098. doi: 10.2196/17098. v22i5e17098
    1. Nolet K, Corno G, Bouchard S. The adoption of new treatment modalities by health professionals and the relative weight of empirical evidence in favor of virtual reality exposure versus mindfulness in the treatment of anxiety disorders. Front Hum Neurosci. 2020;14:86. doi: 10.3389/fnhum.2020.00086. doi: 10.3389/fnhum.2020.00086.
    1. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996 Mar;153(3):321–30. doi: 10.1176/ajp.153.3.321.
    1. Marwaha S, Johnson S. Schizophrenia and employment - a review. Soc Psychiatry Psychiatr Epidemiol. 2004 May;39(5):337–49. doi: 10.1007/s00127-004-0762-4.
    1. Rinaldi M, Killackey E, Smith J, Shepherd G, Singh SP, Craig T. First episode psychosis and employment: a review. Int Rev Psychiatry. 2010;22(2):148–62. doi: 10.3109/09540261003661825.
    1. Bangay S, Preston L. An investigation into factors influencing immersion in interactive virtual reality environments. Stud Health Technol Inform. 1998;58:43–51.
    1. Loomis JM. Presence in virtual reality and everyday life: immersion within a world of representation. Presence Teleoperators Virtual Environ. 2016 Nov 01;25(2):169–74. doi: 10.1162/pres_a_00255.
    1. Wang Y, Zhai G, Chen S, Min X, Gao Z, Song X. Assessment of eye fatigue caused by head-mounted displays using eye-tracking. Biomed Eng Online. 2019 Nov 15;18(1):111. doi: 10.1186/s12938-019-0731-5. 10.1186/s12938-019-0731-5
    1. Malińska M, Zuzewicz K, Bugajska J, Grabowski A. [Subjective sensations indicating simulator sickness and fatigue after exposure to virtual reality] Med Pr. 2014;65(3):361–71.
    1. Aldrich C. Virtual worlds, simulation, and games for education: a unifying view. Innovate J Online Educ. 2009 Apr;5(5)
    1. Birckhead B, Khalil C, Liu X, Conovitz S, Rizzo A, Danovitch I, Bullock K, Spiegel B. Recommendations for methodology of virtual reality clinical trials in health care by an international working group: iterative study. JMIR Ment Health. 2019 Jan 31;6(1):e11973. doi: 10.2196/11973. v6i1e11973

Source: PubMed

3
Abonnere